Business
Long Covid is an elusive target for Big Pharma
This is the second column in a three-part series Heard on the Street on Covid.
The pharmaceutical industry has been developing Covid-19 vaccines and treatments at breakneck speed, saving millions of lives in the process. However, treatments for post-viral disease called Long Covidwhich is plaguing millions of people, is nowhere near being developed.